Higher school of oncology: A decade of advancing oncology training in resource-limited settings.

S Sergei Iugai (The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD) I Irina Gridina (Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation) M Mary Caitlin King (The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD) A Andrei Nikiforchin (The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD) R Ruslan Menzulin (Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation) M Maria Krasavina (Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation) E Ekaterina Baron (Marshfield Medical Center, Marshfield, WI) M Mikhail Skriabin (Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation) P Polina Shilo (Lahta Clinic, St Petersburg, Russian Federation) P Panayotis Ledakis (The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD) I Ilya Fomintsev (International Health Equity Agency (IHEA), Tel Aviv, Israel) V Vadim Gushchin (The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD)

Abstract

e21028 Background: Postgraduate oncology training in resource-limited (RL) countries is often short and lacks structured curricula and a competency focus. Expatriate physicians (EP), familiar with both RL and US healthcare systems, are uniquely positioned to bridge these gaps and support the development of tailored training. This report outlines the 10-year development of the Higher School of Oncology (HSO), a program launched by EP for Russian oncologists in training. Methods: We conducted a descriptive study to assess HSO using an educational program evaluation framework, focusing on its input, processes, and product. Results: HSO began with a small team led by a US-based expatriate oncologist, supported by business and private donors. The first class included 9 medical graduates (acceptance rate [AR] 3.6%). Weekly journal clubs (JC) were the sole teaching format. To date, HSO is a comprehensive educational platform with an expanded team. Funding has diversified with more sponsors, fundraising events, and alumni-created educational courses for external learners. HSO remains competitive (median AR 4.5%) and attracts trainees from 38 Russian regions and 5 other post-Soviet countries. The curriculum has integrated diverse teaching methods to address competencies lacking in standard Russian residency. Over 10 years, 120 trainees have graduated, forming a close-knit community. Most alumni (n=101, 84.2%) remain in clinical practice, with 6 (5.0%) in lead roles(Table 1). Many (n=66, 55.0%) have contributed as teachers or program managers throughout HSO progress. Four trainee-driven national quality improvement (QI) projects have been launched. Conclusions: An EP-driven oncology education model, complementing standard residency in RL settings, is scalable and self-sustainable when trainees and alumni are actively involved. Further evaluation of trainee competencies and program reproducibility is needed. HSO program development. Component Description Input Team 3 EP, 3 local managers Trainees 9 medical graduates Funding 1 business & private donors Process Education Initially Weekly JC Current Seminars, JC Practice simulation (patient communication, tumor board) Electives (biostatistics, genetics) Peer-to-peer education, & in-hospital guidance by alumni Assessment - Biannual evaluation & feedback; capstone project Product Team CEO, program director, 9 managers, 27 teachers (96.3% HSO alumni) Alumni 63 medical, 33 surgical, 5 radiation, 7 pediatric oncologists & 12 pathologists Career & Research 101 (84.2%) - clinical field, 11 (9.2%) - non-clinical role, 3 (2.5%) - full-time research & 4 (3.3%) - non-medical career 97 (90.8%) work in Russia 30 (47.6%) medical oncologists are ESMO-certified 54 (48.3%) authored 1-10 publications, 4 (3.3%) > 50 publications National QI projects HSO Academy (online education), HSO Talks (media), Just Ask & OncoWiki (patient navigation & education)

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (12)

S

Sergei Iugai

The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD

I

Irina Gridina

Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation

M

Mary Caitlin King

The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD

A

Andrei Nikiforchin

The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD

R

Ruslan Menzulin

Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation

M

Maria Krasavina

Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation

E

Ekaterina Baron

Marshfield Medical Center, Marshfield, WI

M

Mikhail Skriabin

Worthwhile Medical Solutions Foundation, Saint Petersburg, Russian Federation

P

Polina Shilo

Lahta Clinic, St Petersburg, Russian Federation

P

Panayotis Ledakis

The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD

I

Ilya Fomintsev

International Health Equity Agency (IHEA), Tel Aviv, Israel

V

Vadim Gushchin

The Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD